11
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Ein Beitrag zur Behandlung von Gefässverschlüssen der Netzhaut durch Fibrinolyse

      research-article
      ,
      Journal of Vascular Research
      S. Karger AG
      Retina, Arterial occlusion, Venous occlusion, Treatment, Streptase

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Fibrinolysis, the breaking up of the fibrin structure of thrombi into low molecular proteins, is a new principle in the treatment of occlusion of the retinal vessels. It has been tried in occlusion of both arterial and venous trunks and branches of the central retinal area. Good results can be obtained with this technique in selected patients. Attention must be paid, however, to the contraindications to the use of streptokinase for fibrinolysis, as these may prove fatal under certain circumstances. The subjective side effects resulting from the use of an extract of cultured β-hemolytic streptococci must be observed and treated.

          Related collections

          Author and article information

          Journal
          JVR
          J Vasc Res
          10.1159/issn.1018-1172
          Journal of Vascular Research
          S. Karger AG
          1018-1172
          1423-0135
          1971
          1971
          18 September 2008
          : 8
          : 6
          : 303-317
          Affiliations
          Universitäts-Augenklinik Hamburg (Direktor: Prof. Dr. H. Sautter)
          Article
          157904 Angiologica 1971;8:303–317
          10.1159/000157904
          a1c47a5a-544e-4a94-9911-d03598984b37
          © 1971 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          Page count
          Pages: 15
          Categories
          Paper

          General medicine,Neurology,Cardiovascular Medicine,Internal medicine,Nephrology
          Venous occlusion,Retina,Streptase,Arterial occlusion,Treatment

          Comments

          Comment on this article